1. 541. Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in HIV-1 Treatment Naïve Patients: Week 48 Results in Subgroups Based on Baseline Viral Load, CD4+ Count, and WHO Clinical Staging. (26th November 2018) Authors: Spinner, Christoph D; Rashbaum, Bruce; Mcdonald, Cheryl; Mussini, Cristina; Luo, Donghan; Jezorwski, John; Brown, Kimberley; Wong, Eric Y Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S201 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Adequate plasma levels of dolutegravir in combination with ritonavir-boosted darunavir: a pharmacokinetic subgroup analysis of the DUALIS study. (7th July 2020) Authors: Weidlich, Simon; Boesecke, Christoph; Schneider, Jochen; Klinker, Hartwig H F; Zink, Alexander; Balogh, Annamaria; Wolf, Eva; Bidner, Helen; Spinner, Christoph D Journal: Journal of antimicrobial chemotherapy Issue: Volume 75:Number 10(2020) Page Start: 3082 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Are 96-week data enough for doravirine to DRIVE FORWARD?. Issue 1 (January 2020) Authors: Spinner, Christoph D; Barber, Tristan John Journal: Lancet Issue: Volume 7:Issue 1(2020) Page Start: e2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Detailed stratified GWAS analysis for severe COVID-19 in four European populations. Issue 23 (15th July 2022) Authors: Degenhardt, Frauke; Ellinghaus, David; Juzenas, Simonas; Lerga-Jaso, Jon; Wendorff, Mareike; Maya-Miles, Douglas; Uellendahl-Werth, Florian; ElAbd, Hesham; Rühlemann, Malte C; Arora, Jatin; Özer, Onur; Lenning, Ole Bernt; Myhre, Ronny; Vadla, May Sissel; Wacker, Eike M; Wienbrandt, Lars; Blandino... Journal: Human molecular genetics Issue: Volume 31:Issue 23(2022) Page Start: 3945 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Dolutegravir Monotherapy as Treatment De-Escalation in HIV-Infected Adults with Virological Control: DoluMono Cohort Results. Issue 2 (February 2017) Authors: Oldenbuettel, Celia; Wolf, Eva; Ritter, Ayla; Noe, Sebastian; Heldwein, Silke; Pascucci, Rita; Wiese, Carmen; Krosigk, Ariane Von; Jaegel-Guedes, Eva; Jaeger, Hans; Balogh, Annamaria; Koegl, Christine; Spinner, Christoph D Journal: Antiviral therapy Issue: Volume 22:Issue 2(2017) Page Start: 169 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Effects of antiretroviral combination therapies F/TAF, E/C/F/TAF and R/F/TAF on insulin resistance in healthy volunteers: The TAF-IR Study. Issue 7 (October 2018) Authors: Spinner, Christoph D; Schulz, Sebastian; Bauer, Ulrike; Schneider, Jochen; Bobardt, Johanna; Werder, Alexander Von; Schmid, Roland M; Zink, Alexander; Wolf, Eva; Iakoubov, Roman Journal: Antiviral therapy Issue: Volume 23:Issue 7(2018) Page Start: 629 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Efficacy and Safety of Switching to Dolutegravir With Boosted Darunavir in Virologically Suppressed Adults With HIV-1: A Randomized, Open-Label, Multicenter, Phase 3, Noninferiority Trial: The DUALIS Study. (13th August 2020) Authors: Spinner, Christoph D; Kümmerle, Tim; Schneider, Jochen; Cordes, Christiane; Heiken, Hans; Stellbrink, Hans-Jürgen; Krznaric, Ivanka; Scholten, Stephan; Jensen, Björn; Wyen, Christoph; Viehweger, Marin; Lehmann, Clara; Sprinzl, Martin; Stoehr, Albrecht; Bickel, Markus; Jessen, Heiko; Obst, Wilfrie... Journal: Open forum infectious diseases Issue: Volume 7:Number 9(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 12 (December 2022) Authors: Hardt, Karin; Vandebosch, An; Sadoff, Jerald; Le Gars, Mathieu; Truyers, Carla; Lowson, David; Van Dromme, Ilse; Vingerhoets, Johan; Kamphuis, Tobias; Scheper, Gert; Ruiz-Guiñazú, Javier; Faust, Saul N; Spinner, Christoph D; Schuitemaker, Hanneke; Van Hoof, Johan; Douoguih, Macaya; Struyf, Frank;... Journal: Lancet infectious diseases Issue: Volume 22:Issue 12(2022) Page Start: 1703 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Ledipasvir plus sofosbuvir fixed-dose combination for 6 weeks in patients with acute hepatitis C virus genotype 1 monoinfection (HepNet Acute HCV IV): an open-label, single-arm, phase 2 study. Issue 2 (February 2017) Authors: Deterding, Katja; Spinner, Christoph D; Schott, Eckart; Welzel, Tania M; Gerken, Guido; Klinker, Hartwig; Spengler, Ulrich; Wiegand, Johannes; zur Wiesch, Julian Schulze; Pathil, Anita; Cornberg, Markus; Umgelter, Andreas; Zöllner, Caroline; Zeuzem, Stefan; Papkalla, Armin; Weber, Kristina; Hardt... Journal: Lancet infectious diseases Issue: Volume 17:Issue 2(2017:Feb.) Page Start: 215 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 7 (July 2021) Authors: Ogbuagu, Onyema; Ruane, Peter J; Podzamczer, Daniel; Salazar, Laura C; Henry, Keith; Asmuth, David M; Wohl, David; Gilson, Richard; Shao, Yongwu; Ebrahimi, Ramin; Cox, Stephanie; Kintu, Alexander; Carter, Christoph; Das, Moupali; Baeten, Jared M; Brainard, Diana M; Whitlock, Gary; Brunetta, Jason... Journal: Lancet Issue: Volume 8:Issue 7(2021) Page Start: e397 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗